You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 1
  • 06.13 A novel preclinical platform for the evaluation of therapeutics for spondyloarthritis (spa) and comorbidities developing in the tga86 murine-tmtnf-driven model

Article info

Article menu
Download PDFPDF
Novel technologies
06.13 A novel preclinical platform for the evaluation of therapeutics for spondyloarthritis (spa) and comorbidities developing in the tga86 murine-tmtnf-driven model

Authors

Citation

Kranidioti K, Karagianni N, Ntari L, et al
06.13 A novel preclinical platform for the evaluation of therapeutics for spondyloarthritis (spa) and comorbidities developing in the tga86 murine-tmtnf-driven model
Annals of the Rheumatic Diseases 2017;76:A65.

Publication history

  • First published March 1, 2017.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions